Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation

By Solomon SR   Tran T   Carter CS   Donnelly S   Hensel N   Schindler J   Bahceci E   Ghetie V   Michálek J   Mavroudis D   Read EJ   Vitetta ES   Barrett AJ  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 395-406

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation

By André-Schmutz I   Cortivo L Dal   Fischer A   Cavazzana-Calvo M  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 102-108

Ashgate Publishing Ltd

Access to resources Recommend Favorite

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

By Kottaridis PD   Milligan DW   Chopra R   Chakraverty RK   Chakrabarti S   Robinson S   Peggs K   Verfuerth S   Pettengell R   Marsh JCW   Schey S   Mahendra P   Morgan GJ   Hale G   Waldmann H   De Elvira MC   Williams CD   Devereux S   Linch DC   Goldstone AH   MacKinnon S  

Cytotherapy, Vol. 3, Iss. 3, 2001-05 ,pp. : 197-201

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation

By Ciceri F   Bonini C   Gallo-Stampino C   Bordignon C  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 144-149

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Conjunctival Scrape Cytology Findings in Patients with Chronic Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation

By  

Acta Cytologica, Vol. 54, Iss. 3, 2011-02 ,pp. : 272-276

Karger

Access to resources Recommend Favorite